A war of words between Chandrababu Naidu and YSR Rajasekhar Reddy lead to commotion in the House.
Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.
The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. According to the latest data from US-based Centers for Medicare and Medicaid Services (CMMS), price erosion in calendar year 2024 (CY24) on a year-to-date (YTD) basis stood at a high of 15 per cent in the oral solid dosage (OSD) segment compared to a low of 1 per cent in CY23. This erosion, according to a report by Antique Stock Broking, was the highest in the last three years.
'Rahul Gandhi's problem is that he doesn't think big.' 'He looks more like an activist, while politics is like a game of chess. You attack and then defend and have a game-plan.'
Research and development (R&D) spending by BSE 100 companies has grown steadily, rising from 0.89 per cent of revenue in FY20 to 1.32 per cent in FY24, averaging around 1 per cent over the period in-between, according to data compiled from Bloomberg and company annual reports. Also, these companies more than doubled their R&D spending in absolute terms over these five years: From Rs 25,041 crore to Rs 63,072 crore. While this reflects a prioritisation of innovation, corporate R&D investment remains relatively conservative.
Corporate earnings from blue-chips like HDFC Bank, ICICI Bank, Donald Trump's swearing-in as the US President, and trading activity of foreign investors are the key factors to drive equity markets this week, analysts said. Trump will be sworn in as the US president for a second term on Monday. This week, several key Nifty-50 companies, including BPCL, HDFC Bank, Hindustan Unilever, Dr Reddy's, UltraTech Cement, JSW Steel and ICICI Bank are scheduled to announce their financial results.
Chandrapuram Ponnusamy Radhakrishnan was sworn in as the 15th Vice President of India, succeeding Jagdeep Dhankhar.
Dr Jaishankar meets up with movie star John Abraham, who plays J P Singh, currently India's ambassador to Israel, in The Diplomat.
rediffGURU Dr Shakeeb Ahmed Khan, a physiotherapist with 13 years of experience, explains how you can prevent injuries and heal from physical pain.
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus.
In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country's pharmaceuticals sector. Sanofi's partnerships with Dr Reddy's, Cipla, and Emcure, AstraZeneca and Mankind Pharma - teaming up for asthma medication distribution - are a few instances of this trend. This strategy allows MNCs to leverage established Indian networks and reach a wider audience. Indian companies also benefit from global brands and expertise, say analysts.
The BSE Healthcare Index is up 19 per cent as compared to BSE Sensex returns of 11 per cent during this period. Nitin Agarwal of DAM Capital highlighted this trend in a report last month. "After a sustained period of underperformance over FY21-23, the BSE Healthcare Index has once again captured the spotlight. "The recent uptick in performance has been driven by hospitals and emerging green shoots in pharmaceutical exports, particularly to the US, along with sustaining momentum in domestic branded formulations," he said.
The first phase of the programme will kick off with vaccinations in Hyderabad on Monday and in Visakhapatnam on Tuesday (May 18) at Apollo facilities.
Marathi film folk were honoured at the Filmfare Awards Marathi 2025.
The November 5 US presidential elections, Federal Reserve interest rate decision, trading activity of foreign investors, and the upcoming quarterly earnings from domestic firms are the major triggers that would influence sentiments in the equity market this week, analysts said. In an eventful week ahead, a host of macroeconomic data announcements and global trends would also drive the markets, experts said. "The upcoming week is poised to be eventful on the global front.
India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.
Indian drugmaker Dr Reddy's Laboratories hopes to launch two-to-three generic products in the United States this year in a bid to increase its share of a lucrative market, its chief executive said.
On Monday, LSG face Delhi Capitals in their season-opener in Visakhapatnam, the first of two DC's home matches to be played at the Dr YS Rajasekhara Reddy ACA-VDCA Stadium this season.
Bollywood stars Jacqueline Fernandez and Ishaan Khatter are slated to deliver perform at the grand finale.
These are the top buyers of the scrapped electoral bonds, the data for which was released by the Election Commission on Thursday.
Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.
'Nobody asked us to work on this. It was on our own that we decided to embark on this journey.'
'There is merit in keeping the central bank's balance sheet strong if the government's fiscal balance sheet is weak.'
According to the recommendations of the Subject Expert Committee (SEC) meeting held on July 30, which have been approved by the Drugs Controller General of India (DCGI), Sputnik-Light is the same as the component-1 of Sputnik V and as its safety and immunogenicity data in the Indian population has already been generated in a trial here, there seems to be inadequate data and justification for conducting a separate, similar trial.
'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'
Russian COVID-19 vaccine Sputnik V vaccine will be available in nine more cities across India, including Bengaluru, Mumbai, Chennai, Visakhapatnam, Baddi, Kolhapur and Miryalaguda, informed the official twitter handle of Sputnik V.
Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India.
Notably, four portfolio companies-- Agnikul, ePlane, CynLr, and GalaxEye -- of deep-tech investor Speciale Invest made it to the list.
As the policy was going to be revised, the BCCI staff including the finance, operations and media department were not paid their daily allowances for the IPL and WPL but now that the policy has been formulated, their dues should be cleared soon.
Benchmark indices declined for the third day running on Tuesday, with the Sensex tumbling 567.98 points amid weak global markets and continuous foreign funds outflow. Investors were risk averse ahead of the RBI's policy decision on Wednesday, traders said. The 30-share BSE Sensex tanked 567.98 points or 1.02 per cent to settle at 55,107.34.
Axis Bank was the top loser in the Sensex pack, shedding around 2 per cent, followed by Reliance Industries, Kotak Bank, Bharti Airtel, Titan, Dr Reddy's and M&M. NSE Nifty fell by 100.55 points to 17,898.65.
Almost three months after announcing his new party, former Karnataka minister and mining baron G Janardhana Reddy on Monday announced 'football' as its poll symbol, the first list of candidates, and also manifesto, ahead of the assembly elections due by May.
Equity benchmark Sensex tumbled over 273 points on Tuesday, tracking losses in index majors Reliance Industries, Dr Reddy's and Axis Bank amid a massive selloff in Chinese markets. Despite opening on a positive note, the 30-share BSE index turned red to end 273.51 points or 0.52 per cent lower at 52,578.76, while the broader NSE Nifty fell 78 points or 0.49 per cent to 15,746.45. Dr Reddy's was the top loser in the Sensex pack, plunging over 10 per cent, after the company reported s 36 per cent decline in consolidated net profit at Rs 380.4 crore for the quarter ended June 30, 2021, on account of higher expenses.
Asian Paints was the top loser in the Sensex pack, tanking around 5 per cent, followed by Reliance Industries, Infosys, Tata Steel, TCS and Dr Reddy's.
Mohit displayed immense game awareness, taking a single to bring Ashutosh on strike, bringing down the equation to five runs in four balls.
UltraTech Cement was the top gainer in the Sensex pack, surging over 3 per cent, followed by L&T, Dr Reddy's, Bajaj Finserv, Sun Pharma, TCS and Kotak Bank. NSE Nifty gained 68.30 points to finish at a record 16,705.20.
While about 8,000 people are in the long list of invitees, the select list features just a few hundred people, including prominent politicians, leading industrialists, top film stars, sportspersons, bureaucrats and diplomats.
